A comparison of coding tumor mutational burden (TMB) between patients with melanoma and epithelial cancer revealed a decreasing trend in non-synonymous coding mutations, from PD-1-naïve melanomas to PD-1-treated melanomas, and further to epithelial cancers.
← all excerpts
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.
1
—
—